Abstract
e15526Background: A combination of 5-fluorouracil/folinic acid and oxaliplatin plus bevacizumab (FOLFOX+BV) is a standard regimen for chemotherapy of metastatic colorectal cancer (mCRC). The aim of...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
